Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVA Trial: Vonoprazan vs Vonoprazan + Itopride in Functional Dyspepsia
NCT07731542Recruiting
- Sponsor
- Asian Institute of Gastroenterology
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised trial of itopride in functional dyspepsia (FD) (2 arms), sponsored by Asian Institute of Gastroenterology. Primary endpoint: Symptom Relief in Functional Dyspepsia at 12 weeks. Started Jan 2026; status: recruiting.
02
Drugs
itopride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT07731542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07731542.